Nelson Guzman
Nelson Guzman is president and founder of Trinity Risk Advisors in Alpharetta, Georgia. He has worked in insurance for 20 years.
Search
Dec 02, 2024
2024 Judicial Review: Significant Court Decisions on Medical Liability Issues
Between fall 2023 and summer 2024, state supreme courts handed down mixed decisions on medical liability issues affecting healthcare professionals.
From
The Doctor’s Advocate
Video Aug 29, 2025
Hospital at Home: A New Model of Care for Acutely Ill Patients
Michael J. Maniaci, MD, Director of Enterprise Virtual Care, Mayo Clinic, presents at the 2025 TDC Group Executive Advisory Board Meeting about hospital at home programs.
Video Oct 16, 2024
What Types of Bias Might Be Present Within AI Tools?
I. Glenn Cohen, JD, Deputy Dean and James A. Attwood and Leslie Williams Professor of Law, Harvard Law School, Faculty Director, Petri-Flom Center for Health Law Policy, Biotechnology, and Bioethics, discusses what biases can be present in AI and how that will affect implementation of the technology in healthcare.
April 03, 2025, Cardiology Magazine
Critical Insights: Lessons From Delayed Diagnosis, Treatment in the ED
John P. Erwin III, MD, MBA, MACC, Chair, Department of Internal Medicine, Prisma Health Upstate; Clinical Professor, School of Medicine Greenville, University of South Carolina; and Debra A. Davidson, MJ, CPHRM, CPPS, Senior Patient Safety Risk Manager, The Doctors Company, part of TDC Group, review how care and treatment delays contribute to poor patient outcomes and medical malpractice litigation.
Professional Education
Module 3: Safe Prescribing of Opioids and CNS Depressants (Innovations and Smart Approaches in Safe Prescribing)
Learn several new concepts and innovation tips. Learn about the new CDC Guidelines about pain. This program will show how to treat pain, opioid withdrawal, and/or opioid addiction. It will show how to taper opioids and you will learn how to conduct “motivational interviewing.” You will examine multimodal approaches for chronic pain, including physical, psych-behavioral, procedural, and pharmacological modalities. You will be encouraged to use tools for prescribing and tapering opioids and benzodiazepines. You will be provided with an overview of the use of CURES 2.0. Lastly, the program will examine how to best screen patients for use of CNS depressants and marijuana to mitigate the potential for contraindications with opioids. This module consists of seven audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
July 27, 2024, PSQH Podcast
PSQH: The Podcast Episode 109 – The Overwhelming Flood of Patient Wearable Data
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, discusses how data from wearables is affecting physicians and patient care.
Plastic Surgery Closed Claims Study Reveals Most Common Case Types
In this study of plastic surgery closed claims, The Doctors Company looks at the most common case types, most common patient injuries, primary drivers / frequent allegations, and strategies for mitigating risk for both cosmetic and reconstructive surgery.
Deferred, Delayed, Disrupted: Mitigating Risks from Care During COVID-19
The pandemic has disrupted healthcare so thoroughly that in some sense, COVID-19 has affected all of healthcare. The effect on care has been stunning in magnitude. By mid-2020, more than 40 percent of U.S. adults had delayed medical care or avoided it entirely, including care for urgent and emergent complaints.
The California Medical Association Selects The Doctors Company as Its Exclusive Medical Professional Liability Insurance Company Corporate Sponsor
The California Medical Association (CMA), representing nearly 50,000 physicians, has chosen The Doctors Company, part of TDC Group, as its exclusive medical professional liability insurance company (MPLI) corporate sponsor.
